Using WhatsApp to educate and support patients in preventing kidney stones
Effectiveness of WhatsApp Education and Support Messages for Urolithiasis Prevention
This study tests whether using WhatsApp to send helpful messages can support people with a history of kidney stones in making better dietary choices and staying hydrated to prevent future stones.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Rabin Medical Center Academic / other |
| Locations | 1 site (Petah Tikva) |
| Trial ID | NCT05627622 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of using WhatsApp to deliver health education and support messages to patients with a history of kidney stones. The intervention focuses on promoting dietary modifications and adequate fluid intake to prevent the recurrence of urinary tract stones. Participants will receive tailored messages that encourage adherence to preventive measures and medication regimens. The study will assess whether this mobile technology approach can improve patient outcomes in managing urolithiasis.
Who should consider this trial
Good fit: Ideal candidates for this study are adults with a personal history of urolithiasis who have a personal mobile phone with WhatsApp.
Not a fit: Patients who are children or cannot read Hebrew will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce the recurrence of kidney stones in patients through improved education and adherence to preventive measures.
How similar studies have performed: While mobile health interventions have shown promise in various health education contexts, this specific approach using WhatsApp for urolithiasis prevention is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Capacity to give informed consent * Personal history of urolithiasis * Stone free status * A personal mobile phone with WhatsApp Messenger® application Exclusion Criteria: * Children * Does not read Hebrew, the language in which the messages are written
Where this trial is running
Petah Tikva
- Rabin Medical Center — Petah Tikva, Israel (Recruiting)
Study contacts
- Principal investigator: MIchael Frumer, MD — Rabin Medical Center
- Study coordinator: MIchael Frumer, MD
- Email: mic1039@gmail.com
- Phone: +972542686959
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.